☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Insights+ Key Biosimilars Events of April 2022
May 5, 2022
Byondis Entered into a Multiple Agreement with medac to Commercialize Trastuzumab Duocarmazine (SYD985) for the Treatment of Cance...
May 5, 2022
AstraZeneca’s Farxiga (dapagliflozin) Meet its Primary Endpoints in the P-III (DELIVER) Trial for Heart Failure with a Preserved E...
May 5, 2022
Novartis Updated Exploratory OS Analysis of Kisqali (ribociclib) in P-III (MONALEESA-3) Trial for the Treatment of HR+/HER2- Advan...
May 5, 2022
Incyte’s Jakavi (ruxolitinib) Receives EC’s Approval as the First Post-Steroid Treatment for Acute and Chronic Graft-Versus-Host D...
May 5, 2022
Jazz Entered into an Exclusive License Agreement with Sumitomo Pharma to Develop and Commercialize DSP-0187 for the Treatment of S...
May 5, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions